Calò, F.; Onorato, L.; Pisaturo, M.; Pinto, A.; Alessio, L.; Monari, C.; Minichini, C.; Arcamone, M.; Di Fraia, A.; Atripaldi, L.;
et al. Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report. Vaccines 2022, 10, 1021.
https://doi.org/10.3390/vaccines10071021
AMA Style
Calò F, Onorato L, Pisaturo M, Pinto A, Alessio L, Monari C, Minichini C, Arcamone M, Di Fraia A, Atripaldi L,
et al. Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report. Vaccines. 2022; 10(7):1021.
https://doi.org/10.3390/vaccines10071021
Chicago/Turabian Style
Calò, Federica, Lorenzo Onorato, Mariantonietta Pisaturo, Antonio Pinto, Loredana Alessio, Caterina Monari, Carmine Minichini, Manuela Arcamone, Alessandra Di Fraia, Luigi Atripaldi,
and et al. 2022. "Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report" Vaccines 10, no. 7: 1021.
https://doi.org/10.3390/vaccines10071021
APA Style
Calò, F., Onorato, L., Pisaturo, M., Pinto, A., Alessio, L., Monari, C., Minichini, C., Arcamone, M., Di Fraia, A., Atripaldi, L., Tiberio, C., & Coppola, N.
(2022). Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report. Vaccines, 10(7), 1021.
https://doi.org/10.3390/vaccines10071021
